武漢佰樂(lè)博代理：Research Grade Elsilimomab

貨號(hào)：DHC15806

產(chǎn)品鏈接：http://www.atagenix.com/product_detail-75569.html

產(chǎn)品購(gòu)買(mǎi)聯(lián)系方式：027-65279366

產(chǎn)品介紹：Elsilimomab (B-E8)是一種抗白介素-6 (IL-6)的IgG1單克隆抗體，其KD為22 pM，IC50為1.4 nM。Elsilimomab可用于多發(fā)性骨髓瘤、腎細(xì)胞癌和類(lèi)風(fēng)濕性關(guān)節(jié)炎(RA)的研究。

通用名：Elsilimomab

純度：>95% by SDS-PAGE.

濃度：1mg/ml

Formulationicon：0.01M PBS, pH 7.4.

內(nèi)毒素：Please contact with the lab for this information.

別名：B-E8

靶點(diǎn);物種：Human IL6

種類(lèi)：Mus musculus

受體鑒定：IgG1-nd

CAS: 468715-71-1

存儲(chǔ)條件：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

Store at +4°C short term (1-2 weeks).

Store at -20 °C 12 months.

Store at -80°C long term.

參考文獻(xiàn)：

Emerging antibodies for the treatment of multiple myeloma. PMID: 27195659

Gateways to clinical trials. PMID: 17235418

Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth. PMID: 27658435